{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T22:36:49Z","timestamp":1784932609393,"version":"3.55.0"},"reference-count":42,"publisher":"Jaypee Brothers Medical Publishing","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.59556\/japi.72.0715","type":"journal-article","created":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T09:22:17Z","timestamp":1751275337000},"page":"83-90","source":"Crossref","is-referenced-by-count":4,"title":["Position of Beta-blockers in the Treatment of Hypertension Today: An Indian Consensus"],"prefix":"10.59556","volume":"72","author":[{"given":"JC","family":"Mohan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devanu Ghosh","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saumitra","family":"Ray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamshed","family":"Dalal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamal","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A Sreenivas","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jabir","family":"Abdullakutty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JPS","family":"Sawhney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2914","reference":[{"key":"key20250630092213_B1","doi-asserted-by":"crossref","first-page":"100271.","DOI":"10.1016\/j.lansea.2023.100271","article-title":"Hypertension treatment cascade among men and women of reproductive age group in India: Analysis of National Family Health Survey-5 (2019-2021).","volume":"23:","author":"Rao Guthi","year":"2023;","journal-title":"Lancet Reg Health Southeast Asia"},{"issue":"(7):","key":"key20250630092213_B2","doi-asserted-by":"crossref","first-page":"474\u2013","DOI":"10.1016\/S2213-8587(23)00119-5","article-title":"Metabolic non-communicable disease health report of India: the ICMR-INDIAB national cross-sectional study (ICMR-INDIAB-17).","volume":"11","author":"Anjana","year":"2023;","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"(3):","key":"key20250630092213_B3","doi-asserted-by":"crossref","first-page":"244\u2013","DOI":"10.4103\/ijmr.ijmr_3096_21","article-title":"The Indian registry on current patient profiles & treatment trends in hypertension (RECORD): one year interim analysis.","volume":"158","author":"Rajadhyaksha","year":"2023;","journal-title":"Indian J Med Res"},{"issue":"(11):","key":"key20250630092213_B4","first-page":"11\u2013","article-title":"Hypertension in young adults in India: perspectives and therapeutic options amongst clinician\u2019s in a cross sectional observational study.","volume":"69","author":"Jadhav","year":"2021;","journal-title":"J Assoc Physicians India"},{"issue":"(2):","key":"key20250630092213_B5","doi-asserted-by":"crossref","first-page":"285\u2013","DOI":"10.1161\/HYPERTENSIONAHA.119.14240","article-title":"High blood pressure and cardiovascular disease.","volume":"75","author":"Fuchs","year":"2020;","journal-title":"Hypertension."},{"issue":"(1):","key":"key20250630092213_B6","doi-asserted-by":"crossref","first-page":"1\u2013","DOI":"10.1016\/j.mjafi.2019.12.005","article-title":"Cardiovascular disease in India: a 360 degree overview.","volume":"76","author":"Sreeniwas Kumar","year":"2020;","journal-title":"Med J Armed Forces India"},{"key":"key20250630092213_B7","unstructured":"Hypertension. WHO. Available at: https:\/\/www.who.int\/india\/health-topics\/hypertension#:~:text=India%20Hypertension%20Control%20Initiative&text=Only%20about%2012%25%20people%20with,of%20total%20deaths%20in%20India"},{"issue":"(39):","key":"key20250630092213_B8","doi-asserted-by":"crossref","first-page":"4043\u2013","DOI":"10.1093\/eurheartj\/ehad192","article-title":"2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes: developed by the task force on the management of cardiovascular disease in patients with diabetes of the European Society of Cardiology (ESC).","volume":"44","author":"Marx","year":"2023;","journal-title":"Eur Heart J"},{"issue":"(1):","key":"key20250630092213_B9","doi-asserted-by":"crossref","first-page":"9.","DOI":"10.1186\/s40885-021-00165-3","article-title":"Efficacy and safety of nebivolol in Korean patients with hypertension by age and sex: a subanalysis from the BENEFIT-KOREA study.","volume":"27","author":"Cho","year":"2021;","journal-title":"Clin Hypertens"},{"issue":"(6):","key":"key20250630092213_B10","doi-asserted-by":"crossref","first-page":"1058\u2013","DOI":"10.1111\/jch.13312","article-title":"A retrospective study evaluating the tolerability and effectiveness of adjunctive antihypertensive drugs in patients with inadequate response to initial treatment.","volume":"20","author":"Ayyagari","year":"2018;","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"(10414):","key":"key20250630092213_B11","doi-asserted-by":"crossref","first-page":"1802\u2013","DOI":"10.1016\/S0140-6736(23)01733-6","article-title":"\u03b2-blockers switched to first-line therapy in hypertension.","volume":"402","author":"Messerli","year":"2023;","journal-title":"Lancet"},{"issue":"(12):","key":"key20250630092213_B12","doi-asserted-by":"crossref","first-page":"1874\u2013","DOI":"10.1097\/HJH.0000000000003480","article-title":"2023 ESH Guidelines for the management of arterial hypertension the Task Force for the management of arterial hypertension of the European Society of Hypertension: endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA).","volume":"41","author":"Mancia","year":"2023;","journal-title":"J Hypertens"},{"issue":"(3):","key":"key20250630092213_B13","doi-asserted-by":"crossref","first-page":"788\u2013","DOI":"10.1161\/HYPERTENSIONAHA.120.12858","article-title":"Starting antihypertensive drug treatment with combination therapy: controversies in hypertension - con side of the argument.","volume":"77","author":"Zhang","year":"2021;","journal-title":"Hypertension"},{"key":"key20250630092213_B14","doi-asserted-by":"crossref","first-page":"2087064.","DOI":"10.1155\/2019\/2087064","article-title":"Heart rate in hypertension: Review and expert opinion.","volume":"2019:","author":"Dalal","year":"2019;","journal-title":"Int J Hypertens"},{"issue":"(5):","key":"key20250630092213_B15","first-page":"14\u2013","article-title":"BEAT survey: a cross-sectional study of resting heart rate in young (18-55 year) hypertensive patients.","volume":"63","author":"Rao","year":"2015;","journal-title":"J Assoc Physicians India"},{"issue":"(6):","key":"key20250630092213_B16","doi-asserted-by":"crossref","first-page":"478\u2013","DOI":"10.1007\/s11906-012-0306-3","article-title":"Heart rate and blood pressure: any possible implications for management of hypertension?","volume":"14","author":"Reule","year":"2012;","journal-title":"Curr Hypertens Rep"},{"key":"key20250630092213_B17","doi-asserted-by":"crossref","first-page":"337\u2013","DOI":"10.2147\/VHRM.S285907","article-title":"\u03b2-blockade for patients with hypertension, ischemic heart disease or heart failure: where are we now?","volume":"17:","author":"Pathak","year":"2021;","journal-title":"Vasc Health Risk Manag"},{"key":"key20250630092213_B18","doi-asserted-by":"crossref","first-page":"429\u2013","DOI":"10.1016\/B978-0-12-812348-5.00028-3","article-title":"Endothelium and arterial hypertension.","volume-title":"Endothelium and cardiovascular diseases.","author":"Consolim-Colombo","year":"2018."},{"issue":"(4):","key":"key20250630092213_B19","doi-asserted-by":"crossref","first-page":"439\u2013","DOI":"10.1080\/02688697.2017.1297367","article-title":"Nebivolol attenuates cerebral vasospasm both by increasing endothelial nitric oxide and by decreasing oxidative stress in an experimental subarachnoid haemorrhage.","volume":"31","author":"Aladag","year":"2017;","journal-title":"Br J Neurosurg"},{"issue":"(2):","key":"key20250630092213_B20","doi-asserted-by":"crossref","first-page":"173\u2013","DOI":"10.1007\/s40119-018-0117-y","article-title":"Risk of hospitalization for cardiovascular events with \u03b2-blockers in hypertensive patients: a retrospective cohort study.","volume":"7","author":"Basile","year":"2018;","journal-title":"Cardiol Ther"},{"issue":"(3):","key":"key20250630092213_B21","doi-asserted-by":"crossref","first-page":"257\u2013","DOI":"10.1023\/A:1026180325278","article-title":"Comparison of the new cardioselective beta-blocker nebivolol with bisoprolol in hypertension: the Nebivolol, Bisoprolol Multicenter Study (NEBIS).","volume":"17","author":"Czuriga","year":"2003;","journal-title":"Cardiovasc Drugs Ther"},{"issue":"(1):","key":"key20250630092213_B22","doi-asserted-by":"crossref","first-page":"63.","DOI":"10.1186\/s43044-020-00099-5","article-title":"Effect of carvedilol versus nebivolol on insulin resistance among non-diabetic, non-ischemic cardiomyopathy with heart failure.","volume":"72","author":"Metwally","year":"2020;","journal-title":"Egypt Heart J"},{"issue":"(4):","key":"key20250630092213_B23","doi-asserted-by":"crossref","first-page":"296\u2013","DOI":"10.1111\/j.1751-7176.2011.00454.x","article-title":"Thiazide diuretics and \u03b2-blockers in the treatment of hypertension in diabetes mellitus.","volume":"13","author":"Sander","year":"2011;","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"(5 Suppl):","key":"key20250630092213_B24","first-page":"1891\u2013","article-title":"Effect of nebivolol beneficial on lipid profile and glycemic control in comparison with atenolol in patients with type 2 DM with concomitant hypertension.","volume":"34","author":"Majid","year":"2021;","journal-title":"Pak J Pharm Sci"},{"issue":"(9):","key":"key20250630092213_B25","first-page":"833\u2013","article-title":"2023 AHA\/ACC\/ACCP\/ASPC\/NLA\/PCNA guideline for the management of patients with chronic coronary disease.","volume":"82","author":"Arnold","year":"2023;","journal-title":"J Am Coll Cardiol"},{"issue":"(6):","key":"key20250630092213_B26","doi-asserted-by":"crossref","first-page":"376\u2013","DOI":"10.1038\/jhh.2017.8","article-title":"Protective effects of nebivolol from oxidative stress to prevent hypertension-related target organ damage.","volume":"31","author":"Coats","year":"2017;","journal-title":"J Hum Hypertens"},{"issue":"(3):","key":"key20250630092213_B27","doi-asserted-by":"crossref","first-page":"209\u2013","DOI":"10.1136\/hrt.2010.207365","article-title":"\u03b2-blockade with nebivolol for prevention of acute ischaemic events in elderly patients with heart failure.","volume":"97","author":"Ambrosio","year":"2011;","journal-title":"Heart"},{"issue":"(13):","key":"key20250630092213_B28","doi-asserted-by":"crossref","first-page":"1049\u2013","DOI":"10.4244\/EIJY20M07_01","article-title":"An EAPCI expert consensus document on ischaemia with non-obstructive coronary arteries in collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology & Microcirculation Endorsed by Coronary Vasomotor Disorders International Study Group.","volume":"16","author":"Kunadian","year":"2021;","journal-title":"EuroIntervention"},{"issue":"(8):","key":"key20250630092213_B29","doi-asserted-by":"crossref","first-page":"568\u2013","DOI":"10.5543\/tkda.2022.21237","article-title":"The safety and tolerability of nebivolol in hypertensive patients with coronary artery disease and left ventricular ejection fraction \u226540%: a population-based cohort study (Nebivolol-TR Study).","volume":"50","author":"Alt\u0131n","year":"2022;","journal-title":"Turk Kardiyol Dern Ars"},{"issue":"(5):","key":"key20250630092213_B30","doi-asserted-by":"crossref","first-page":"1019\u2013","DOI":"10.1097\/HJH.0000000000003109","article-title":"Nebivolol and incident cardiovascular events in hypertensive patients compared with nonvasodilatory beta blockers.","volume":"40","author":"Huck","year":"2022;","journal-title":"J Hypertens"},{"issue":"(10):","key":"key20250630092213_B31","doi-asserted-by":"crossref","first-page":"89\u2013","DOI":"10.18087\/cardio.2021.10.n1119","article-title":"Possibilities and limitations of the use of beta-blockers in patients with cardiovascular disease and chronic obstructive pulmonary disease.","volume":"61","author":"Karoli","year":"2021;","journal-title":"Kardiologiia"},{"issue":"(2):","key":"key20250630092213_B32","doi-asserted-by":"crossref","first-page":"72\u2013","DOI":"10.5455\/medarh.2019.73.72-75","article-title":"Beta-blocker use in moderate and severe chronic obstructive pulmonary disease.","volume":"73","author":"Zvizdic","year":"2019;","journal-title":"Med Arch"},{"issue":"(12):","key":"key20250630092213_B33","first-page":"e6453.","article-title":"Comparison of nebivolol and bisoprolol for cardiovascular mortality in hypertensive patients.","volume":"11","author":"Kumar","year":"2019;","journal-title":"Cureus"},{"issue":"(17):","key":"key20250630092213_B34","doi-asserted-by":"crossref","first-page":"1783\u2013","DOI":"10.1007\/s40265-018-0999-y","article-title":"A critical review of nebivolol and its fixed-dose combinations in the treatment of hypertension.","volume":"78","author":"Cicero","year":"2018;","journal-title":"Drugs"},{"key":"key20250630092213_B35","doi-asserted-by":"crossref","first-page":"1212.","DOI":"10.3389\/fphar.2018.01212","article-title":"Comparison of long-term clinical implications of beta-blockade in patients with obstructive airway diseases exposed to beta-blockers with different \u03b21-adrenoreceptor selectivity: an Italian population-based cohort study.","volume":"9:","author":"Sessa","year":"2018;","journal-title":"Front Pharmacol"},{"issue":"(2):","key":"key20250630092213_B36","doi-asserted-by":"crossref","first-page":"138\u2013","DOI":"10.2174\/1573402118666220627120254","article-title":"Target blood pressure and combination therapy: Focus on angiotensin receptor blockers combination with either calcium channel blockers or beta-blockers.","volume":"18","author":"Farag","year":"2022;","journal-title":"Curr Hypertens Rev"},{"issue":"(5):","key":"key20250630092213_B37","first-page":"630\u2013","article-title":"Comparison of effects of Nebivolol, carvedilol and irbesartan on left ventricular hypertrophy associated with hypertension.","volume":"18","author":"Degirmenci","year":"2014;","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"(4):","key":"key20250630092213_B38","doi-asserted-by":"crossref","first-page":"270\u2013","DOI":"10.1111\/jch.12071","article-title":"Effects of add-on nebivolol on blood pressure and glucose parameters in hypertensive patients with prediabetes.","volume":"15","author":"Deedwania","year":"2013;","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"(6):","key":"key20250630092213_B39","doi-asserted-by":"crossref","first-page":"567\u2013","DOI":"10.1042\/CS20040068","article-title":"Sympathetic overactivity in ischaemic heart disease.","volume":"106","author":"Malliani","year":"2004;","journal-title":"Clin Sci (Lond)"},{"issue":"(4):","key":"key20250630092213_B40","doi-asserted-by":"crossref","first-page":"316\u2013","DOI":"10.1159\/000446184","article-title":"Nebivolol versus carvedilol or metoprolol in patients presenting with acute myocardial infarction complicated by left ventricular dysfunction.","volume":"25","author":"Ozaydin","year":"2016;","journal-title":"Med Princ Pract"},{"issue":"(2):","key":"key20250630092213_B41","doi-asserted-by":"crossref","first-page":"152\u2013","DOI":"10.2174\/157489007780832588","article-title":"Nebivolol: more than a highly selective beta-blocker.","volume":"2","author":"Karter","year":"2007;","journal-title":"Recent Pat Cardiovasc Drug Discov"},{"key":"key20250630092213_B42","doi-asserted-by":"crossref","first-page":"9\u2013","DOI":"10.1016\/j.ejim.2021.03.035","article-title":"The use of \u03b2-blockers in patients with heart failure and comorbidities: doubts, certainties and unsolved issues.","volume":"88:","author":"Paolillo","year":"2021;","journal-title":"Eur J Intern Med"}],"container-title":["Journal of The Association of Physicians of India"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T09:22:27Z","timestamp":1751275347000},"score":1,"resource":{"primary":{"URL":"https:\/\/japi.org\/article\/japi-72-10-83"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":42,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["10.59556\/japi.72.0715"],"URL":"https:\/\/doi.org\/10.59556\/japi.72.0715","relation":{},"ISSN":["0004-5772"],"issn-type":[{"value":"0004-5772","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]}}}